Professor, Chief Physician, Director of Prostate Reproductive Surgery, Urology Center, Daping Hospital, Third Military Medical University. 65438-0989 After graduating from the Third Military Medical University, he has been engaged in urology, andrology, clinical and scientific research. He has many years of clinical experience in urology, systematic professional theoretical knowledge and rich clinical experience, and has unique research on the diagnosis and treatment of various common, frequently-occurring and complicated diseases in urology and andrology, and has gradually formed a clinical development direction and characteristics with minimally invasive and cavity urology techniques as the main focus, focusing on andrology, dysuria and pediatric urology. Especially in the treatment of male reproductive dysfunction, such as erectile dysfunction, premature ejaculation, transurethral minimally invasive treatment of spermatorrhea and ejaculatory duct obstruction, electrovaporization and green laser vaporization for benign prostatic hyperplasia, radical prostatectomy, comprehensive treatment of chronic prostatitis, plastic surgery for reproductive development disorder and deformity, hypospadias plasty, concealed penis lengthening, urethral stricture and complicated urethral stricture. Artificial urethral muscle implantation for complete urinary incontinence, Prolift total pelvic repair for pelvic organ prolapse, TVT-O treatment for female stress urinary incontinence, comprehensive treatment for male infertility, etc. At the same time, great achievements have been made in percutaneous nephrolithotomy, ureteroscopy and various single-hole laparoscopic urolithiasis operations.
In scientific research, we have long been committed to constructing sperm antigen contraceptive vaccine by genetic engineering and studying the function and interaction of sperm-specific proteins. From 2000/KLOC-0 to 2003, he went to the Institute of Urology, the First Hospital of Peking University to continue his postdoctoral study, engaged in the research on testicular reproductive physiology and sperm antigen contraception, and was awarded the item of "Study on Multi-parameter Selection and Establishment of Sperm Cells from Human Testis" by the National Natural Foundation of China 1 and the item of "Study on Recombinant Human Polyvalent Sperm Antigen Contraceptive Vaccine" by the China Postdoctoral Fund 1. From 2004 165438+ 10 to February 2007, I went to the Center for Reproductive Health and Contraception of the University of Virginia to study the interaction of male reproductive related proteins, and established my own research direction in this field. His main achievement is the discovery of a brand-new protein FSCB that has not been reported in the world. The discovery and in-depth study of this protein won two national natural funds. There are many provincial and ministerial topics, 6 articles in English, many abstracts, and 4 invited speeches at international conferences. One of them was published in the internationally renowned magazine JBC (impact factor 5.5438+0). * * * The first author or correspondent has published more than 50 research papers at home and abroad.